SINOVAC has initiated a phase I/II clinical trial on its bivalent vaccine in China since September 2023. The results from Phase I/II clinical trial demonstrated that the vaccine candidate has ...

Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need; This col ...

TECNO is set to redefine durability in form-factor smartphones, breaking barriers and making cutting-edge innovation accessible to everyone. The brand is launching its highly anticipated PHANTOM V2 ...

Inauguration of CMA Terminals Khalifa Port Boosts the Port’s Total Container Capacity by 23% to almost 10m TEUs ...

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis ...

Dublin, Ireland & Costa Mesa, Calif., United States: ...

The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has ...

Nabat, New Abu Dhabi Climate Tech Venture, to use AI and Robotics to Restore Mangroves and Boost Climate Resilience ...

Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing ...

With Temporal Cloud on Google Cloud, developers can take advantage of Temporal-as-a-service running on Google Cloud infrastructure. Customers benefit from enhanced security with traffic kept inside ...

Kioxia Corporation, a world leader in memory solutions, today announced that the cryptographic module used in KIOXIA CM7 ...

Outperforming on key 2024 financial targets, Allianz has set ambitious financial targets through 2027 at its Capital Markets ...